Beyond mere weight loss, patients regularly report increased energy levels, reduced joint pain, better sleep quality, improved self-esteem, and decreased risks for heart disease, diabetes, and other obesity-related conditions
Ongoing trials such as BELIEVE focus on functional outcomes in high-risk groups, including people with type 2 diabetes or sarcopenic obesity
It neutralizes free radicals, reduces oxidative stress at the cellular level, and inhibits tyrosinase, the enzyme that drives melanin production
Docking studies revealed that compounds with aromatic amine residues interact with the large pocket of DPP-4, while compounds with cyclic secondary amine residues bind in the small pocket, similar to Vildagliptin
If prescribed, youll receive guidance on how to use the medicationtypically a once-weekly injectionas well as ongoing support for nutrition, lifestyle, and behavioral changes